share_log

Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3

Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3

基準測試通過買入評級啟動 Nutex 健康覆蓋率,宣布目標價為 3 美元
Benzinga Real-time News ·  2022/12/23 08:34

Benchmark analyst Bill Sutherland initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $3.

基準分析師Bill Sutherland以買入評級啟動Nutex Health(納斯達克:NUTX)的報道,並宣佈目標價為3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論